At this concentration, a 2mg target dose corresponds to 0.1mL which on a standard 1mL insulin syringe equals 10 units
Super GHK-Copper Cream: Water, ethylhexyl palmitate, squalane, stearic acid, cetyl alcohol, glyceryl stearate, PEG-100 stearate, PPG 2 myristyl ether propionate, copper tripeptide-1 (GHK-Copper), phenoxyethanol, C10-30 cholesterol/lanosterol esters, polysorbate 80, allantoin, leucine, lavandula angustifolia (lavender) oil, aloe barbadensis (aloe vera) powder, sodium salicylate, vitamin E TPGS (tocophersolan), vitamin E (as d-alpha tocopherol plus mixed tocopherols: d-beta, d-delta and d-gamma tocopherol)
Limited Clinical Safety Data : The human safety profile remains unclear because the evidence is primarily based on animal and laboratory studies rather than large-scale clinical trials
Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1